Hemophilia risk factors: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Hemophilia}} | {{Hemophilia}} | ||
{{CMG}}; {{AE}} {{Simrat}} | {{CMG}}; {{AE}} {{Sab}}{{Simrat}} | ||
==Overview== | ==Overview== | ||
The most potent risk factor in the development of hemophilia is the family history of hemophilia. Other [[Risk factor|risk factors]] include [[Male|male sex]] and [[Cancer|malignancies]]. | The most potent risk factor in the development of hemophilia is the family history of hemophilia. Other [[Risk factor|risk factors]] include [[Male|male sex]] and [[Cancer|malignancies]]. |
Revision as of 18:38, 16 January 2019
Hemophilia Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Hemophilia risk factors On the Web |
American Roentgen Ray Society Images of Hemophilia risk factors |
Risk calculators and risk factors for Hemophilia risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sabawoon Mirwais, M.B.B.S, M.D.[2]Simrat Sarai, M.D. [3]
Overview
The most potent risk factor in the development of hemophilia is the family history of hemophilia. Other risk factors include male sex and malignancies.
Risk Factors
- The most potent risk factor in the development of hemophilia is the family history of hemophilia.[1][2]
- Male sex is also a very common risk factor.[3]
- Current history of malignancy can also be considered a risk factor on account of the association between malignancies and acquired hemophilia.[4]
References
- ↑ Mannucci PM, Tuddenham EG (June 2001). "The hemophilias--from royal genes to gene therapy". N. Engl. J. Med. 344 (23): 1773–9. doi:10.1056/NEJM200106073442307. PMID 11396445.
- ↑ Ingram, G I (1976). "The history of haemophilia". Journal of Clinical Pathology. 29 (6): 469–479. doi:10.1136/jcp.29.6.469. ISSN 0021-9746.
- ↑ Di Michele DM, Gibb C, Lefkowitz JM, Ni Q, Gerber LM, Ganguly A (March 2014). "Severe and moderate haemophilia A and B in US females". Haemophilia. 20 (2): e136–43. doi:10.1111/hae.12364. PMID 24533955.
- ↑ Napolitano M, Siragusa S, Mancuso S, Kessler CM (January 2018). "Acquired haemophilia in cancer: A systematic and critical literature review". Haemophilia. 24 (1): 43–56. doi:10.1111/hae.13355. PMID 28960809.